LP
GSK icon

LMR Partners’s GSK GSK Stock Holding History

LMR Partners’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-28,200
Closed -$1.38M – 1636
2025
Q4 		$1.38M Hold
28,200
– – ﹤0.01% 905
2025
Q3 		$1.22M Sell
28,200
-19,100
-40% -$746K 0.01% 871
2025
Q2 		$1.82M Buy
+47,300
New +$1.81M 0.01% 668

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

LMR Partners's GSK Position: Q2 2026 in Review

LMR Partners held its GSK (GSK) position steady in Q2 2026 at 980,479 shares worth $51.4M. The position accounts for 0.19% of the portfolio, ranked #108.

LMR Partners first reported a position in GSK in Q3 2022 and has held it in 13 quarters since. The position peaked at $128M in Q2 2024. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • LMR Partners held 980,479 shares of GSK worth $51.4M as of Q2 2026.
  • LMR Partners left its GSK share count unchanged in Q2 2026.
  • GSK made up 0.19% of LMR Partners's portfolio in Q2 2026, its #108 holding.
  • LMR Partners first reported a position in GSK in Q3 2022 and has held it in 13 quarters since.
  • LMR Partners's GSK position peaked at $128M in Q2 2024.
  • 1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on LMR Partners's 13F filing for Q2 2026, filed 14 Aug 2026.